Related Experiment Video
Updated: Jun 10, 2025

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
Published on: November 21, 2012
Methamphetamine-Induced Blood Pressure Sensitization Correlates with Morphological Alterations within A1/C1
Carla Letizia Busceti1, Domenico Bucci1, Antonio Damato1
1Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, 86077 Pozzilli, Italy.
Repeated methamphetamine (METH) use sensitizes blood pressure and reduces key neurons in the brainstem
Area of Science:
- Neuroscience
- Cardiovascular Science
- Pharmacology
Background:
- Methamphetamine (METH) is a potent psychostimulant drug with significant abuse potential.
- Repeated METH administration is known to induce behavioral sensitization.
- METH affects cardiovascular function, including blood pressure, but the underlying neural mechanisms are not fully understood.
Purpose of the Study:
- To investigate whether repeated METH administration sensitizes systolic and diastolic blood pressure (SBP and DBP).
- To determine if alterations occur within A1/C1 neurons in the brainstem's vasomotor center following METH exposure.
- To explore the cellular and molecular changes associated with METH-induced cardiovascular effects.
Main Methods:
- C57Bl/6J male mice received daily METH (5 mg/kg) for 5 consecutive days.
- Blood pressure (SBP and DBP) was monitored using tail-cuff plethysmography.
- Immunohistochemistry was employed to assess catecholamine neurons, glutamic acid decarboxylase, and markers of neuronal stress and degeneration (Fluoro-Jade B, α-synuclein, phospho-cJun, heat shock protein-70, p62/sequestosome).
Main Results:
- A sensitized response in both SBP and DBP was observed after repeated METH administration.
- A significant decrease in catecholamine neurons was found within the A1/C1 regions of the ventrolateral medulla.
- This neuronal decrease was linked to reduced free radicals and phospho-cJun, and increased heat shock protein-70 and p62/sequestosome, but not degeneration markers.
- Arterial reactivity remained unchanged, suggesting central mechanisms for blood pressure sensitization.
Conclusions:
- Reiterated METH administration can lead to persistent increases in blood pressure.
- METH may sensitize cardiovascular responses, potentially increasing the risk of adverse events.
- These findings highlight the neurobiological underpinnings of METH-induced cardiovascular complications and their relevance in stress contexts.
More Related Videos
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which...
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

